PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 29883801-0 2019 Glucose-derived acetate and ACSS2 as key players in cisplatin resistance in bladder cancer. Cisplatin 52-61 acyl-CoA synthetase short chain family member 2 Homo sapiens 28-33 29883801-7 2019 The relevance of ACSS2 in cisplatin resistance was further confirmed by the abrogation of resistance by an ACSS2 inhibitor and, finally, by the higher expression of ACSS2 in the patient tissues with cisplatin resistance. Cisplatin 26-35 acyl-CoA synthetase short chain family member 2 Homo sapiens 17-22 29883801-7 2019 The relevance of ACSS2 in cisplatin resistance was further confirmed by the abrogation of resistance by an ACSS2 inhibitor and, finally, by the higher expression of ACSS2 in the patient tissues with cisplatin resistance. Cisplatin 26-35 acyl-CoA synthetase short chain family member 2 Homo sapiens 107-112 29883801-7 2019 The relevance of ACSS2 in cisplatin resistance was further confirmed by the abrogation of resistance by an ACSS2 inhibitor and, finally, by the higher expression of ACSS2 in the patient tissues with cisplatin resistance. Cisplatin 26-35 acyl-CoA synthetase short chain family member 2 Homo sapiens 107-112 29883801-7 2019 The relevance of ACSS2 in cisplatin resistance was further confirmed by the abrogation of resistance by an ACSS2 inhibitor and, finally, by the higher expression of ACSS2 in the patient tissues with cisplatin resistance. Cisplatin 199-208 acyl-CoA synthetase short chain family member 2 Homo sapiens 17-22 29883801-7 2019 The relevance of ACSS2 in cisplatin resistance was further confirmed by the abrogation of resistance by an ACSS2 inhibitor and, finally, by the higher expression of ACSS2 in the patient tissues with cisplatin resistance. Cisplatin 199-208 acyl-CoA synthetase short chain family member 2 Homo sapiens 107-112 29883801-7 2019 The relevance of ACSS2 in cisplatin resistance was further confirmed by the abrogation of resistance by an ACSS2 inhibitor and, finally, by the higher expression of ACSS2 in the patient tissues with cisplatin resistance. Cisplatin 199-208 acyl-CoA synthetase short chain family member 2 Homo sapiens 107-112 31638228-6 2019 Moreover, it was shown that ACSS2 inhibition by siRNA not only greatly interfered with proliferation under NS but also participated in DNA repair after cisplatin treatment via PCNA suppression, and the acceleration of cell death was dependent on the activation of the AMPK pathway as revealed by the Annexin V/PI and TUNEL assay results. Cisplatin 152-161 acyl-CoA synthetase short chain family member 2 Homo sapiens 28-33 31558821-8 2019 The results indicate that EP + CsP significantly downregulated 14 key glycolysis proteins (including ENO1, LDHA, LDHB, ACSS2, ALDOA, and PGK1), compared to CsP alone. Cisplatin 31-34 acyl-CoA synthetase short chain family member 2 Homo sapiens 119-124